vimarsana.com

Latest Breaking News On - Pharmaceuticals stock down - Page 1 : vimarsana.com

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) CEO Sells $9,203,857 52 in Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the transaction, the chief executive officer now owns 55,134 shares […]

Frazier Life Sciences Management L P Grows Stock Holdings in Mirum Pharmaceuticals, Inc (NASDAQ:MIRM)

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9 48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9 48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Barometer Capital Management Inc

Barometer Capital Management Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,487 shares of the pharmaceutical company’s stock after selling 3,342 shares during the period. Vertex Pharmaceuticals makes up approximately 1.2% […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.